Dana-Farber Cancer Institute donations received

This is an online portal with information on donations that were announced publicly (or have been shared with permission) that were of interest to Vipul Naik. The git repository with the code for this portal, as well as all the underlying data, is available on GitHub. All payment amounts are in current United States dollars (USD). The repository of donations is being seeded with an initial collation by Issa Rice as well as continued contributions from him (see his commits and the contract work page listing all financially compensated contributions to the site) but all responsibility for errors and inaccuracies belongs to Vipul Naik. Current data is preliminary and has not been completely vetted and normalized; if sharing a link to this site or any page on this site, please include the caveat that the data is preliminary (if you want to share without including caveats, please check with Vipul Naik). We expect to have completed the first round of development by the end of March 2022. See the about page for more details. Also of interest: pageview data on analytics.vipulnaik.com, tutorial in README, request for feedback to EA Forum.

Table of contents

Basic donee information

ItemValue
Country
Wikipedia pagehttps://en.wikipedia.org/wiki/Dana%E2%80%93Farber_Cancer_Institute

Donee donation statistics

Cause areaCountMedianMeanMinimum10th percentile 20th percentile 30th percentile 40th percentile 50th percentile 60th percentile 70th percentile 80th percentile 90th percentile Maximum
Overall 17 238,373 626,300 -674 -582 45,000 100,000 100,000 238,373 250,000 250,000 750,000 2,185,657 3,518,240
Global health 10 100,000 720,470 -674 -674 -582 100,000 100,000 100,000 213,685 238,373 750,000 2,185,657 3,518,240
1 2,500 2,500 2,500 2,500 2,500 2,500 2,500 2,500 2,500 2,500 2,500 2,500 2,500
Science 4 246,341 197,835 45,000 45,000 45,000 246,341 246,341 246,341 250,000 250,000 250,000 250,000 250,000
Human Sciences 2 544,350 1,324,276 544,350 544,350 544,350 544,350 544,350 544,350 2,104,202 2,104,202 2,104,202 2,104,202 2,104,202

Donation amounts by donor and year for donee Dana-Farber Cancer Institute

Donor Total 2018 2016 2015 2014 2013 2012 2011 2010 2009 2008 2003
Bill and Melinda Gates Foundation (filter this donee) 7,204,698.62 0.00 750,000.00 -674.18 2,185,657.00 0.00 238,373.00 213,685.00 -582.20 200,000.00 3,618,240.00 0.00
John Templeton Foundation (filter this donee) 2,648,552.00 0.00 2,104,202.00 0.00 0.00 544,350.00 0.00 0.00 0.00 0.00 0.00 0.00
Chan Zuckerberg Initiative (filter this donee) 791,341.00 791,341.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Smith Richardson Foundation (filter this donee) 2,500.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 2,500.00
Total 10,647,091.62 791,341.00 2,854,202.00 -674.18 2,185,657.00 544,350.00 238,373.00 213,685.00 -582.20 200,000.00 3,618,240.00 2,500.00

Full list of donations in reverse chronological order (17 donations)

DonorAmount (current USD)Amount rank (out of 17)Donation dateCause areaURLInfluencerNotes
Chan Zuckerberg Initiative250,000.0062018Sciencehttps://chanzuckerberg.com/grants-ventures/grants/-- Program: Human Cell Atlas. Grant period: 2018–2019. This grant supports building a Cell Dynamics Portal for data visualization, exploration, and analysis with emphasis on state transitions, developmental trajectories, genetic differences, inferred dynamics, and interactions. (PI: Chris Sander, Human Cell Atlas Computational Tools RFA).
Chan Zuckerberg Initiative250,000.0062018Sciencehttps://chanzuckerberg.com/grants-ventures/grants/-- Program: Human Cell Atlas. Grant period: 2018–2019. This grant supports the generation of a comprehensive benchmark data set of single-cell lineage trees with endpoint cell states measurements using smFSIH and scRNA-seq for systematically comparing computational approaches and identifying standards for multi-mode integration. (PI:Sahand Hormoz, Human Cell Atlas Computational Tools RFA).
Chan Zuckerberg Initiative45,000.00142018Sciencehttps://chanzuckerberg.com/grants-ventures/grants/-- Program: Human Cell Atlas. Grant period: 2018–2019. This grant supports providing R / Bioconductor software as a coherent programmatic interface to the HCA and to enable scalable interactive statistical analysis of single-cell data. (PI: Rafael Irizarry, Human Cell Atlas Computational Tools RFA).
Chan Zuckerberg Initiative246,341.0082018Sciencehttps://chanzuckerberg.com/grants-ventures/grants/-- Program: Human Cell Atlas. Grant period: 2018–2019. This grant supports the development of an integrative computational pipeline to combine the strengths of sequencing- and imaging-based single-cell technologies. (PI: Guo-Cheng Yuan, Human Cell Atlas Computational Tools RFA).
Bill and Melinda Gates Foundation750,000.0042016-08-25Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to provide immunogens and a vaccine strategy to elicit broadly neutralizing antibodies (BNAbs) against the HIV-1 gp41 membrane proximal external region (MPER) segment affording protective global immunity to prevent HIV-1/AIDS; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
John Templeton Foundation2,104,202.0032016Human Scienceshttps://templeton.org/grants/grant-database-- For project Advancing Health, Religion, and Spirituality Research from Public Health to End of Life; Project leaders: Tracy Balboni,Tyler VanderWeele. Affected regions: USA; affected countries: FIXME.
Bill and Melinda Gates Foundation-674.18172015-01-27Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to develop a vaccine imunogen capable of eliciting broadly neutralizing antibodies to prevent infection with the HIV strains most common in Africa; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation2,185,657.0022014-07-28Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to provide immunogens and a vaccine strategy to elicit broadly neutralizing antibodies (BNAbs) against the HIV-1 gp41 membrane proximal external region (MPER) segment affording protective global immunity to prevent HIV-1/AIDS; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
John Templeton Foundation544,350.0052013Human Scienceshttps://templeton.org/grants/grant-database-- For project Transforming Neglect & Hostility to Engagement & Hospitality: An Interdisciplinary Foundation for a Future Program on Religion, Health & Medicine; Project leaders: Michael Balboni,Tracy Balboni. Affected regions: USA; affected countries: FIXME.
Bill and Melinda Gates Foundation238,373.0092012-03-07Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to develop a vaccine imunogen capable of eliciting broadly neutralizing antibodies to prevent infection with the HIV strains most common in Africa; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation213,685.00102011-02-25Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to develop a vaccine imunogen capable of eliciting broadly neutralizing antibodies to prevent infection with the HIV strains most common in Africa; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation-582.20162010-08-11Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to develop Hydrocarbon-Stapled GP41 Immunogens. Hydrocarbon-Stapled GP41 Immunogens.. Investment start date: 5/1/2009 to end date: 4/30/2010. Grantee name: Dana-Farber Cancer Institute; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation100,000.00112009-02-26Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to develop a new vaccine platform for HIV based on the hypothesis that immunodominant regions of the virus may be irrelevant to neutralizing the virus and also prevent access to neutralizing epitopes in conserved regions; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation100,000.00112009-02-26Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to develop Hydrocarbon-Stapled GP41 Immunogens. Hydrocarbon-Stapled GP41 Immunogens.. Investment start date: 5/1/2009 to end date: 4/30/2010. Grantee name: Dana-Farber Cancer Institute; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation3,518,240.0012008-10-03Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to develop a vaccine imunogen capable of eliciting broadly neutralizing antibodies to prevent infection with the HIV strains most common in Africa; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation100,000.00112008-09-08Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to test an innovative approach to HIV prevention that uses lactobacillus bacteria to carry anti-HIV antibodies, peptides, and other inhibitors to colonize the gastrointestinal tract and provide long-lasting HIV protection; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Smith Richardson Foundation2,500.00152003--http://conservativetransparency.org/donor/smith-richardson-foundation/--